Skip to main content
Ad Account Rescue

Meta rejected our peptide or ketamine ad. What does it mean?

On this page

Meta's ad policies don't use the word peptide or ketamine, so a rejected peptide or ketamine ad was judged under a broader rule, and the reason Meta gives tells you which one. Two rules in Meta's Drugs and Pharmaceuticals policy fit these ads. One bars ads that promote "illicit or recreational drugs, or other unsafe substances, products or supplements, as determined by Meta at its sole discretion." The other covers prescription drugs. Meta says "Promoting prescription drugs is not allowed without authorization from Meta." Telehealth providers and online pharmacies need LegitScript certification before they can apply. Meta's rejected ad guide says its email links to Business Support Home "where you can find the reason for the rejection." Read that reason. If it cites prescription drugs, get authorized if your business is eligible, or rewrite the ad around your clinic and its consultations so it no longer promotes the drug. If it cites unsafe substances, Meta's policy describes no authorization route, so rewrite the ad the same way. Renaming or misspelling the compound doesn't change what the ad promotes. This page from Curve Compliance sets out what Meta's and FDA's own pages say.

Meta's review decides whether the ad runs. What your website sends Meta after the click is the part you control, and that is where Curve Compliance helps a peptide, hormone or ketamine clinic. Curve sends conversions server-side to Meta Conversions API, Google Ads, TikTok, Microsoft Advertising and LinkedIn under neutral event names, so the event name Meta receives doesn't name the treatment. Curve detects PHI-like patterns, such as condition names and form answers, before data reaches an ad platform, and its Event Logs show what was sent and accepted. Curve's team does the setup, customers are typically live in about a week, and Curve signs a BAA on every plan. Book a call with Curve.

Which Meta rule your ad hit

Open the rejection in Business Support Home and match the reason to one of these. A peptide, hormone or ketamine clinic ad can run into four rules on Meta's own policy pages:

  • Unsafe substances. Meta files this rule under "High-Risk Drugs, Non-Medical Drugs and Entheogens". Ads can't "Encourage the consumption of illicit, recreational, or other potentially unsafe drugs, products or supplements". The one exception Meta lists is references "for the purposes of political advocacy, news, and awareness campaigns as long as they don't promote the sale or consumption of those substances". Meta's page describes no authorization route for this rule. (Drugs and Pharmaceuticals)
  • Prescription drugs. Only authorized advertisers can promote a prescription drug, and only certain business types can be authorized. The section below covers who qualifies. (About Meta's Prescription Drugs advertising policy)
  • Health and wellness. Ads for "dietary, health, or weight loss or weight gain products and services must be targeted to people at least 18 years or older". They can't make "promises of specific outcomes within a set timeframe without disclaimers or qualifiers". For prescription weight loss products, Meta points back to its drug policy. (Health and Wellness)
  • Personal attributes. Ads "must not contain content that asserts or implies personal attributes", and the list includes "physical or mental health (including medical conditions)". (Privacy Violations and Personal Attributes)

Meta's policies name no peptide and no ketamine

The words peptide and ketamine don't appear in Meta's Drugs and Pharmaceuticals policy, its Health and Wellness policy or its help page on unsafe substances. Meta hasn't published a list of allowed or banned peptides. The call is Meta's, because the rule covers substances "as determined by Meta at its sole discretion." No approval is permanent either. Meta's Advertising Standards say "Ads remain subject to review and re-review at all times", so an ad that ran last month can still be rejected.

Meta's help page shows the kind of ad it rejects under this rule: "This once a day pill of human growth hormone makes losing weight easier." Its advice is to "Try advertising products that are recognized as safe by industry professionals". The same page says unsafe substances "include but aren't limited to":

  • Anabolic steroids
  • Chitosan
  • Comfrey
  • Dehydroepiandrosterone
  • Ephedra
  • Human growth hormones

Where FDA stands on compounded peptides (October 2026)

Meta's policy pages don't tie their review to FDA's lists. Clinics still ask where FDA stands, so here is what FDA's own pages and the federal review record show on October 26, 2026. Talk to your counsel about what your clinic may compound, prescribe or claim.

  • The rule. FDA says state-licensed physicians and pharmacists that compound under section 503A "may only compound drug products using bulk drug substances that" meet a USP or NF monograph, are "components of FDA-approved drug products", or "Appear on FDA's list of bulk drug substances that can be used in compounding (the 503A bulks list)". FDA's interim policy sorts nominated substances into three categories while it evaluates them, but FDA says it "does not intend to place bulk drug substances nominated on or after January 7, 2025, into these categories." (FDA: section 503A bulk drug substances)
  • Category 2. This holds substances where "FDA has identified significant safety risks relating to the use of these substances in compounding pending further evaluation" (FDA). FDA's category 2 page lists several peptides under the 503A or 503B interim policies, including growth hormone releasing peptide-2 (GHRP-2), GHRP-6, ipamorelin acetate and kisspeptin-10.
  • Withdrawn nominations. The same page lists BPC-157, TB-500, CJC-1295, AOD-9604, KPV, MOTs-C, Semax, Epitalon and others under "Bulk drug substances nominated but withdrawn". These were "previously in category 2 of the interim policies" and "were withdrawn by the nominators". FDA's table still gives each one an entry under "Potential significant safety risks".
  • The July meeting. FDA's Pharmacy Compounding Advisory Committee met on July 23 and 24, 2026, to discuss BPC-157, KPV, TB-500, MOTs-C, emideltide, Semax and Epitalon, substances "being considered for inclusion on the 503A Bulks List". FDA notes that advisory committees "make non-binding recommendations to the FDA". (FDA meeting page)
  • The pending notice. On October 14, 2026, the Office of Information and Regulatory Affairs (OIRA) received an FDA notice titled "Interim Access Policy for Compounding Using Certain Peptides", RIN 0910-ZD94, and lists it as pending review (OIRA record). A Federal Register search on October 26 found no published notice. The OIRA record gives only the title, so which peptides the notice covers isn't public. Curve's October 2026 compliance news tracks it.

If your ad promotes a prescription drug

Eligibility comes first. Meta says "Eligibility for authorization is limited to online pharmacies, telehealth providers, and pharmaceutical manufacturers." It defines a telehealth provider as "an entity that promotes or facilitates access to online health-related services, such as the prescription of pharmaceutical products for consumers via telecommunications and digital communication technologies." Meta's pages describe no authorization route for an in-person clinic that isn't one of those three.

Meta says "Meta requires telehealth providers to be actively certified with LegitScript before submitting an application." Online pharmacies have the same requirement. The policy itself adds that prescription drug ads must "include a disclaimer to consult a licensed health professional or obtain a valid prescription". The application steps are in Meta's prescription drug rules and LegitScript, what certification involves is in LegitScript certification for healthcare ads, and pharmacies can read Curve for online pharmacies. Once authorized, Meta says advertisers can run these ads as long as they:

  • "Only target people in eligible countries (United States, Canada or New Zealand)."
  • "Only target people in the countries in which they are certified."
  • "Only target people 18 years or older."
  • "Comply with all other applicable policies."

Ketamine clinic ads on Meta

The Meta policy and help pages cited here don't mention ketamine, esketamine or Spravato, so a ketamine ad is read against the same rules as any other drug or health ad. For Google's rules, see Ketamine Clinic Google Ads. For channel planning, see Ketamine Clinic Marketing. For the federal rule on prescribing controlled substances by telemedicine, see DEA Telemedicine Rule 2027. On Meta, three points follow from its rules:

  • If the ad promotes ketamine as a prescription treatment, the prescription drug rule applies, and authorization is open only to online pharmacies, telehealth providers and pharmaceutical manufacturers.
  • Copy that encourages using a substance, rather than seeing a clinician, sits close to the unsafe substances rule above, for which Meta's page describes no authorization route.
  • Copy about depression or anxiety meets the personal attributes rule. Meta's own examples allow "Depression counseling" and reject "Depression getting you down? Get help now." (Privacy Violations and Personal Attributes)

Promote the clinic, not the compound

The route that needs no authorization is an ad about the care, not the substance: the consultation, the clinicians, the clinic and how to book. Meta's prescription drug page says "advertisers don't need authorization to run ads that only" do one of the two things below.

The landing page has to match. Meta's Advertising Standards say "The products and services promoted in an ad must match those promoted on the landing page." So an educational ad that links to a page selling a named compound can be judged by that page. The wider copy rules for this vertical are in Peptide and Hormone Clinic Ads: Policy Boundaries.

  • "Educate, advocate or give public service announcements related to prescription drugs"
  • "Promote telehealth services generally"

What to change in the ad and on the landing page

  1. Read the reason. Open Business Support Home from Meta's email and note the reason Meta gives. Meta Business Support Home: read your account status shows where to look.
  2. Pick a path. If the ad must name, price or offer delivery of a prescription drug and your business is eligible, get LegitScript certification and Meta's authorization first. That authorization is under the prescription drug rule; Meta's Drugs and Pharmaceuticals policy describes no authorization route for substances it treats as unsafe. Otherwise, rewrite the ad around the consultation.
  3. Take out what signals drug promotion. Meta's prescription drug page lists what authorized advertisers can do, including "Listing the price of the prescription drug", "Offering paid or free delivery of prescription drugs to customer" and "Specifying availability (e.g. indicating that prescription drugs are in-stock)". Without authorization, keep compound names, prices, shipping offers and stock claims out of the copy, image, video and landing page.
  4. Check every part Meta reviews. Meta's rejected ad guide recommends reviewing "the image, video, text, targeting or landing page". Remove outcome promises tied to a timeframe, and any line that tells the reader they have a condition.
  5. Set the ad set to people 18 or older. Meta's Health and Wellness rule requires it for health products and services, and its prescription drug rule requires it for authorized ads.
  6. Request another review only if you believe the rejection was wrong. Meta says "We aim to review and provide a decision within 48 hours." If the ad is rejected again, "it will stay rejected and you won't be able to submit another review request for the same ad." (How to troubleshoot a rejected ad)
  7. Check what your site sends to Meta. Curve Compliance's free website scan lists the pixels and trackers on a page, and Peptide Ads: Why Meta Conversions Stop covers the tracking side.

What not to do

Talk to Curve

Meta decides whether a peptide or ketamine ad runs. What your site sends Meta after the click is up to you. Curve's team reviews what your website sends to Meta, Google and TikTok with you, shows what in that data is likely triggering a flag, and sets up server-side conversions under neutral event names. Curve detects PHI-like patterns before data reaches an ad platform, and its Event Logs show what was sent and accepted. Curve Compliance is SOC 2 Type II, includes consent management and signs a BAA on every plan. To get started, book a call with Curve.

How Curve helps

  • Curve sends conversions server-side to Meta Conversions API, Google Ads, TikTok, Microsoft Advertising and LinkedIn, with neutral event names and a fixed list of fields for each platform.
  • Curve detects PHI-like patterns, such as condition names, form answers and emails in URLs, before data reaches an ad platform.
  • Curve's Event Logs show what was sent to each platform and what it accepted.
  • Curve keeps attribution through booking tools such as IntakeQ, Calendly and Jane, so a booked consultation is credited to the ad that sent it.
  • Curve's free website scan lists the pixels and trackers on a page.
  • Curve Compliance is SOC 2 Type II and signs a BAA on every plan. Curve's team does the setup for you, typically live in about a week.

Frequently asked questions

Does Meta allow peptide ads?

None of Meta's drug, health or unsafe substances policy pages names peptides, so Meta judges what each ad promotes. Ads can't promote "unsafe substances" "as determined by Meta at its sole discretion", and ads that promote a prescription drug need Meta's authorization (Drugs and Pharmaceuticals).

Can a ketamine clinic advertise on Facebook and Instagram?

Meta's pages don't name ketamine. What they restrict is promoting the drug: prescription drug ads need Meta's authorization, which is limited to "online pharmacies, telehealth providers, and pharmaceutical manufacturers", while ads that "Promote telehealth services generally" don't need it (About Meta's Prescription Drugs advertising policy). Copy must not assert or imply that the reader has a condition such as depression (Personal Attributes).

Do we need LegitScript to advertise a peptide clinic on Meta?

Only to promote a prescription drug. Meta says "Meta requires telehealth providers to be actively certified with LegitScript before submitting an application." Ads that only "Promote telehealth services generally" don't need authorization (Meta Business Help Center). See LegitScript certification for healthcare ads.

Can we run educational ads about peptides or ketamine on Meta?

It depends on which rule Meta applies. For prescription drugs, Meta lets advertisers "Educate, advocate or give public service announcements related to prescription drugs" without authorization (Meta Business Help Center). For substances Meta treats as unsafe, the only exception it lists is references "for the purposes of political advocacy, news, and awareness campaigns as long as they don't promote the sale or consumption of those substances" (Drugs and Pharmaceuticals). The landing page counts too: "The products and services promoted in an ad must match those promoted on the landing page" (Advertising Standards).

Has FDA allowed BPC-157 for compounding?

Not on FDA's published record as of October 26, 2026. BPC-157 isn't on the 503A bulks list in 21 CFR 216.23, and FDA's category 2 page lists it under "Bulk drug substances nominated but withdrawn", with an entry under "Potential significant safety risks". FDA's advisory committee discussed it on July 23, 2026, and such committees "make non-binding recommendations to the FDA" (FDA). An FDA notice titled "Interim Access Policy for Compounding Using Certain Peptides" has been pending review at OIRA since October 14, and the record gives only its title (OIRA record).

Does Google treat peptide and ketamine ads the same way?

Google uses its own policies and certifications, so check them separately. See Google Ads unapproved substances and Ketamine Clinic Google Ads.

How does Curve help a peptide or ketamine clinic on Meta?

Meta decides the ad, and Curve Compliance handles the tracking behind it. Curve sends conversions to Meta Conversions API server-side under neutral event names, detects PHI-like patterns before data reaches an ad platform, and shows what Meta accepted in its Event Logs. Curve signs a BAA on every plan. Book a call with Curve.

Sources

Last verified

Talk to Curve about the data side of your restriction

Book a call and Curve's team will look at what your site sends to Meta, Google and TikTok, and show you the compliant setup that keeps your campaigns optimizing.

Book a call